Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homescience news

      science news

      Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology
      Health

      Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 4th Symposium of the Canadian Society for Virology

      June 8, 2022
      Tonix Pharmaceuticals Announces Presentation at the 2022 BIO International Convention
      Health

      Tonix Pharmaceuticals Announces Presentation at the 2022 BIO International Convention

      June 6, 2022
      Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States
      Health

      Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

      June 2, 2022
      « 1 … 14 15 16

       

      LATEST NEWS

      • Investing News Goldman Sachs Q1 2026 Earnings Insights
      • Investing News Earnings Season Kicks Off with Key Reports
      • Investing News TSMC Reports Q1 Record Revenue
      • Investing News Uniqlo’s Impact on Retail Market
      • Investing News Levi Strauss Q1 2026 Earnings Report

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026